Idaho Pharmacy Board
Jurisprudence Exam
(MPJE): Comprehensive
SBE Question Bank
PART 0: THE NAVIGATOR
● Tier 1 (Questions 1–28) - Foundational Syntax & Application: Core Idaho Pharmacy Act
(HB 200) definitions, licensure timelines, dispensing limits, and standard-of-care
frameworks.
● Tier 2 (Questions 29–58) - Complex Application & Simulation: Schedule II prescription
alterations, risk-based inspection outcomes, PDMP compliance, and autonomous
prescribing mechanics.
● Tier 3 (Questions 59–88) - Grandmaster Synthesis: High-stakes scenarios synthesizing
veterinary compounding (GFI 256), Ivermectin (SB 1211) OTC mandates, telehealth
integrations, and multi-variable licensure transitions.
PART I: THE PRIMER
Mastering this Elite Test Bank forges you into a definitive legal authority on the modern Idaho
Pharmacy Act, directly translating to flawless licensure execution and absolute clinical
compliance. By replacing rote memorization with a surgical understanding of standard-of-care
frameworks, you will navigate complex regulatory gray areas with elite professional intuition.
● The "Critical Axioms" Cheat Sheet:
○ Statute Over Rule: As of July 1, 2025 (HB 200), Idaho administrative rules (IDAPA
24.36.01) have been nullified and integrated directly into statute (Title 54, Chapter
17).
○ Standard of Care is Supreme: Fixed mandates (e.g., specific CE hours, strict
technician ratios) are abolished; practice within the universally accepted Idaho
Community Standard of Care.
○ The Unalterable Four: On a Schedule II prescription, you may alter almost anything
after prescriber consultation EXCEPT the patient's name, the drug's name, the
prescriber's signature, and the date written.
○ End of Business Day Data: All controlled substance dispensing must be reported to
the Idaho PDMP by the end of the business day.
○ Biennial Alignment: CS inventories and all individual licenses (based on birthdate)
operate on a strict biennial (2-year) timeline.
PART II: THE ELITE TEST BANK
Tier 1 - Foundational Syntax & Application
,Q1: An Idaho pharmacist born in an odd year is renewing their license on July 1, 2025. Based
on the Division of Occupational and Professional Licenses (DOPL) transition rules, which action
is MOST ACCURATE? A) The license renews for 1 year at the standard fee to align with the
new statute. B) The license renews for 2 years, expiring on their birthdate, and the fee is
doubled. C) The license renews for 1 year, with biennial renewal delayed until 2026. D) The
license renews for 2 years, expiring on December 31st, with no fee change.
● The Answer: B (The license renews for 2 years, expiring on their birthdate, and the fee is
doubled)
● Distractor Analysis:
○ A is incorrect: Licensees born in odd years immediately transition to a 2-year cycle
in 2025.
○ C is incorrect: The 2026 delay applies exclusively to licensees born in even years.
○ D is incorrect: Licenses expire on the birthdate, not the calendar year-end, requiring
a doubled fee for the extended period.
The Mentor's Analysis: The DOPL licensure modernization eliminates bulk administrative
bottlenecks by anchoring expirations to birthdates. When facing transition periods, the
immediate priority is mapping the birth year to the implementation phase. By utilizing the
odd/even birth year rule, you bypass the common trap of miscalculating expiration dates.
Professional/Academic Intuition: Odd years double up in 2025; even years double up in
2026.
Q2: Under the 2026 risk-based inspection model, which factor LEAST dictates a pharmacy's
subsequent inspection interval? A) The complexity of compounding practices performed on-site.
B) A previous disciplinary action against the Pharmacist-in-Charge. C) The fixed annual
statutory requirement for all retail drug outlets. D) The introduction of an innovative
pharmaceutical care service.
● The Answer: C (The fixed annual statutory requirement for all retail drug outlets)
● Distractor Analysis:
○ A is incorrect: Practice complexity directly impacts the risk classification.
○ B is incorrect: Disciplinary history is a primary metric for determining risk.
○ D is incorrect: Innovative practices trigger more frequent inspections for safety
verification.
The Mentor's Analysis: Idaho abolished rigid, one-size-fits-all annual inspection timelines. When
managing facility compliance, the immediate priority is recognizing that performance dictates
oversight. By utilizing the risk-based model, the Board bypasses the common trap of wasting
resources on highly compliant pharmacies. Professional/Academic Intuition: Compliance
history buys operational autonomy; high risk equals high scrutiny.
Q3: A prescriber omitted the patient's first name on a Schedule II prescription for Oxycodone.
Based on Idaho Board policy, what is the ONLY legal action? A) Contact the prescriber, verbally
verify the name, document the change, and dispense. B) Refuse to fill and require the patient to
obtain a newly written, original prescription. C) Add the first name based on the patient's ID and
dispense. D) Process the prescription as a Schedule III medication to bypass strict C-II rules.
● The Answer: B (Refuse to fill and require the patient to obtain a newly written, original
prescription)
● Distractor Analysis:
○ A is incorrect: A pharmacist is strictly prohibited from altering the patient's name on
a C-II.
○ C is incorrect: Pharmacists cannot unilaterally add or alter a patient's name on a
C-II.
, ○ D is incorrect: Processing a C-II as a C-III is a severe violation of the Controlled
Substances Act.
The Mentor's Analysis: The DEA and Idaho Board enforce strict boundaries on C-II alterations
to prevent diversion. When facing an incomplete C-II, the immediate priority is auditing the
Unalterable Four. By utilizing the rigid prohibition on name, drug, signature, and date, you
bypass the trap of over-accommodating a prescriber's error. Professional/Academic Intuition:
You can change the dose, but never the identity of the patient, the drug, the date, or the
doctor.
Q4: A pharmacist independently prescribes a UTI antibiotic under Idaho Code 54-1734. The
patient has an established primary care physician (PCP). What is the reporting requirement? A)
The pharmacist is exempt because the condition is self-limiting. B) The pharmacist must notify
the patient's PCP within 5 business days. C) The pharmacist must upload the prescription data
to the Idaho PDMP by the end of the day. D) The pharmacist must secure a collaborative
practice agreement (CPA) prior to dispensing.
● The Answer: B (The pharmacist must notify the patient's PCP within 5 business days)
● Distractor Analysis:
○ A is incorrect: Closing a gap in care via independent prescribing mandates PCP
notification.
○ C is incorrect: PDMP reporting applies to controlled substances, not routine
antibiotics.
○ D is incorrect: Independent prescribing for minor conditions under 54-1734 does not
require a CPA.
The Mentor's Analysis: Independent prescriptive authority expands access but requires
collaborative communication. When prescribing autonomously, the immediate priority is
maintaining the patient's broader medical record. By utilizing the 5-day notification rule, you
bypass the trap of fragmenting patient care. Professional/Academic Intuition: Prescribe
independently, but communicate collaboratively within 5 business days.
Q5: For a license renewal in 2026, which continuing education (CE) standard MUST an Idaho
pharmacist meet? A) Exactly 15 hours of CE annually, with 2 hours in pharmacy law. B) An
attestation of completing sufficient CE germane to their practice setting to maintain competence.
C) A hardcopy certificate from ACPE proving 30 hours per biennial cycle. D) Completion of an
Idaho jurisprudence exam in lieu of CE.
● The Answer: B (An attestation of completing sufficient CE germane to their practice
setting to maintain competence)
● Distractor Analysis:
○ A is incorrect: HB 200 abolished fixed hour and specific category requirements.
○ C is incorrect: The rigid 30-hour biennial metric is a legacy rule eliminated by
statute.
○ D is incorrect: Jurisprudence exams are for initial licensure, not CE replacement.
The Mentor's Analysis: Idaho treats pharmacists as advanced professionals capable of
self-directing their education. When renewing a license, the immediate priority is ensuring CE
aligns with actual clinical practice. By utilizing the standard-of-care attestation, you bypass the
trap of tracking arbitrary hour metrics. Professional/Academic Intuition: Competence is
measured by clinical relevance, not hours on a clock.
Q6: A patient requests Ivermectin over-the-counter (OTC). Under Idaho SB 1211, how MUST
the pharmacist proceed? A) Dispense the Ivermectin but mandate the patient sign a liability
waiver. B) Refuse the sale without a valid prescription. C) Sell the Ivermectin OTC and
optionally offer counseling on dosage and toxicity. D) Process the sale through the Idaho PDMP
, to monitor diversion.
● The Answer: C (Sell the Ivermectin OTC and optionally offer counseling on dosage and
toxicity)
● Distractor Analysis:
○ A is incorrect: SB 1211 does not require waivers; it deregulates the transaction.
○ B is incorrect: The statute explicitly allows the sale without a prescription.
○ D is incorrect: Ivermectin is not a controlled substance requiring PDMP tracking.
The Mentor's Analysis: Legislative mandates occasionally override traditional prescription
classifications. When handling SB 1211 requests, the immediate priority is compliance with the
OTC designation. By utilizing the optional counseling framework, you bypass the trap of
unlawfully obstructing a legally deregulated sale. Professional/Academic Intuition: Offer clinical
expertise, but do not use it as a barrier to an authorized OTC sale.
Q7: A pharmacy dispenses a Schedule III controlled substance on Tuesday at 2:00 PM. Under
Idaho Code 37-2730A, what is the ABSOLUTE DEADLINE to report this to the PDMP? A) By
2:00 PM on Wednesday. B) By the end of the business day on Tuesday. C) Within 72 hours of
dispensing. D) By Friday at 5:00 PM.
● The Answer: B (By the end of the business day on Tuesday)
● Distractor Analysis:
○ A is incorrect: The next-day reporting rule was legislatively amended to
end-of-business-day.
○ C is incorrect: 72 hours is a legacy metric for emergency oral C-II prescriptions.
○ D is incorrect: Weekly reporting severely violates rapid-tracking mandates.
The Mentor's Analysis: The speed of data dictates the effectiveness of prescription monitoring.
When dispensing a controlled substance, the immediate priority is real-time database integrity.
By utilizing end-of-day reporting, you bypass the trap of relying on outdated 24-hour grace
periods. Professional/Academic Intuition: If the drug leaves the pharmacy today, the data
hits the PDMP today.
Q8: A pharmacist-in-charge (PIC) is determining the technician-to-pharmacist ratio. Under the
current Idaho Pharmacy Act, which standard dictates this? A) A strict 1:6 ratio. B) A 1:8 ratio if
two technicians are nationally certified. C) Staffing must be adequate to safely provide services
under the applicable standard of care. D) A 1:3 ratio for dispensing, but unlimited for
administrative tasks.
● The Answer: C (Staffing must be adequate to safely provide services under the applicable
standard of care)
● Distractor Analysis:
○ A is incorrect: Fixed numerical ratios were abolished.
○ B is incorrect: The permanent statute relies entirely on professional judgment
regarding safety, not specific integer caps.
○ D is incorrect: Idaho does not artificially bifurcate dispensing vs. administrative
ratios in statute.
The Mentor's Analysis: Regulatory reform shifted operational safety from arbitrary math to
professional accountability. When staffing a facility, the immediate priority is evaluating workload
complexity versus staff competency. By utilizing standard-of-care principles, you bypass the trap
of relying on statutory integers. Professional/Academic Intuition: The limit is defined by safety,
not by a statutory number.
Q9: A drug outlet experiences a change in its majority ownership. Under Idaho Code 54-1731,
what is the required timeline for reporting this to the Board? A) At least 10 days prior. B)
Immediately upon signing. C) Within 30 days following the event. D) During the next biennial
Jurisprudence Exam
(MPJE): Comprehensive
SBE Question Bank
PART 0: THE NAVIGATOR
● Tier 1 (Questions 1–28) - Foundational Syntax & Application: Core Idaho Pharmacy Act
(HB 200) definitions, licensure timelines, dispensing limits, and standard-of-care
frameworks.
● Tier 2 (Questions 29–58) - Complex Application & Simulation: Schedule II prescription
alterations, risk-based inspection outcomes, PDMP compliance, and autonomous
prescribing mechanics.
● Tier 3 (Questions 59–88) - Grandmaster Synthesis: High-stakes scenarios synthesizing
veterinary compounding (GFI 256), Ivermectin (SB 1211) OTC mandates, telehealth
integrations, and multi-variable licensure transitions.
PART I: THE PRIMER
Mastering this Elite Test Bank forges you into a definitive legal authority on the modern Idaho
Pharmacy Act, directly translating to flawless licensure execution and absolute clinical
compliance. By replacing rote memorization with a surgical understanding of standard-of-care
frameworks, you will navigate complex regulatory gray areas with elite professional intuition.
● The "Critical Axioms" Cheat Sheet:
○ Statute Over Rule: As of July 1, 2025 (HB 200), Idaho administrative rules (IDAPA
24.36.01) have been nullified and integrated directly into statute (Title 54, Chapter
17).
○ Standard of Care is Supreme: Fixed mandates (e.g., specific CE hours, strict
technician ratios) are abolished; practice within the universally accepted Idaho
Community Standard of Care.
○ The Unalterable Four: On a Schedule II prescription, you may alter almost anything
after prescriber consultation EXCEPT the patient's name, the drug's name, the
prescriber's signature, and the date written.
○ End of Business Day Data: All controlled substance dispensing must be reported to
the Idaho PDMP by the end of the business day.
○ Biennial Alignment: CS inventories and all individual licenses (based on birthdate)
operate on a strict biennial (2-year) timeline.
PART II: THE ELITE TEST BANK
Tier 1 - Foundational Syntax & Application
,Q1: An Idaho pharmacist born in an odd year is renewing their license on July 1, 2025. Based
on the Division of Occupational and Professional Licenses (DOPL) transition rules, which action
is MOST ACCURATE? A) The license renews for 1 year at the standard fee to align with the
new statute. B) The license renews for 2 years, expiring on their birthdate, and the fee is
doubled. C) The license renews for 1 year, with biennial renewal delayed until 2026. D) The
license renews for 2 years, expiring on December 31st, with no fee change.
● The Answer: B (The license renews for 2 years, expiring on their birthdate, and the fee is
doubled)
● Distractor Analysis:
○ A is incorrect: Licensees born in odd years immediately transition to a 2-year cycle
in 2025.
○ C is incorrect: The 2026 delay applies exclusively to licensees born in even years.
○ D is incorrect: Licenses expire on the birthdate, not the calendar year-end, requiring
a doubled fee for the extended period.
The Mentor's Analysis: The DOPL licensure modernization eliminates bulk administrative
bottlenecks by anchoring expirations to birthdates. When facing transition periods, the
immediate priority is mapping the birth year to the implementation phase. By utilizing the
odd/even birth year rule, you bypass the common trap of miscalculating expiration dates.
Professional/Academic Intuition: Odd years double up in 2025; even years double up in
2026.
Q2: Under the 2026 risk-based inspection model, which factor LEAST dictates a pharmacy's
subsequent inspection interval? A) The complexity of compounding practices performed on-site.
B) A previous disciplinary action against the Pharmacist-in-Charge. C) The fixed annual
statutory requirement for all retail drug outlets. D) The introduction of an innovative
pharmaceutical care service.
● The Answer: C (The fixed annual statutory requirement for all retail drug outlets)
● Distractor Analysis:
○ A is incorrect: Practice complexity directly impacts the risk classification.
○ B is incorrect: Disciplinary history is a primary metric for determining risk.
○ D is incorrect: Innovative practices trigger more frequent inspections for safety
verification.
The Mentor's Analysis: Idaho abolished rigid, one-size-fits-all annual inspection timelines. When
managing facility compliance, the immediate priority is recognizing that performance dictates
oversight. By utilizing the risk-based model, the Board bypasses the common trap of wasting
resources on highly compliant pharmacies. Professional/Academic Intuition: Compliance
history buys operational autonomy; high risk equals high scrutiny.
Q3: A prescriber omitted the patient's first name on a Schedule II prescription for Oxycodone.
Based on Idaho Board policy, what is the ONLY legal action? A) Contact the prescriber, verbally
verify the name, document the change, and dispense. B) Refuse to fill and require the patient to
obtain a newly written, original prescription. C) Add the first name based on the patient's ID and
dispense. D) Process the prescription as a Schedule III medication to bypass strict C-II rules.
● The Answer: B (Refuse to fill and require the patient to obtain a newly written, original
prescription)
● Distractor Analysis:
○ A is incorrect: A pharmacist is strictly prohibited from altering the patient's name on
a C-II.
○ C is incorrect: Pharmacists cannot unilaterally add or alter a patient's name on a
C-II.
, ○ D is incorrect: Processing a C-II as a C-III is a severe violation of the Controlled
Substances Act.
The Mentor's Analysis: The DEA and Idaho Board enforce strict boundaries on C-II alterations
to prevent diversion. When facing an incomplete C-II, the immediate priority is auditing the
Unalterable Four. By utilizing the rigid prohibition on name, drug, signature, and date, you
bypass the trap of over-accommodating a prescriber's error. Professional/Academic Intuition:
You can change the dose, but never the identity of the patient, the drug, the date, or the
doctor.
Q4: A pharmacist independently prescribes a UTI antibiotic under Idaho Code 54-1734. The
patient has an established primary care physician (PCP). What is the reporting requirement? A)
The pharmacist is exempt because the condition is self-limiting. B) The pharmacist must notify
the patient's PCP within 5 business days. C) The pharmacist must upload the prescription data
to the Idaho PDMP by the end of the day. D) The pharmacist must secure a collaborative
practice agreement (CPA) prior to dispensing.
● The Answer: B (The pharmacist must notify the patient's PCP within 5 business days)
● Distractor Analysis:
○ A is incorrect: Closing a gap in care via independent prescribing mandates PCP
notification.
○ C is incorrect: PDMP reporting applies to controlled substances, not routine
antibiotics.
○ D is incorrect: Independent prescribing for minor conditions under 54-1734 does not
require a CPA.
The Mentor's Analysis: Independent prescriptive authority expands access but requires
collaborative communication. When prescribing autonomously, the immediate priority is
maintaining the patient's broader medical record. By utilizing the 5-day notification rule, you
bypass the trap of fragmenting patient care. Professional/Academic Intuition: Prescribe
independently, but communicate collaboratively within 5 business days.
Q5: For a license renewal in 2026, which continuing education (CE) standard MUST an Idaho
pharmacist meet? A) Exactly 15 hours of CE annually, with 2 hours in pharmacy law. B) An
attestation of completing sufficient CE germane to their practice setting to maintain competence.
C) A hardcopy certificate from ACPE proving 30 hours per biennial cycle. D) Completion of an
Idaho jurisprudence exam in lieu of CE.
● The Answer: B (An attestation of completing sufficient CE germane to their practice
setting to maintain competence)
● Distractor Analysis:
○ A is incorrect: HB 200 abolished fixed hour and specific category requirements.
○ C is incorrect: The rigid 30-hour biennial metric is a legacy rule eliminated by
statute.
○ D is incorrect: Jurisprudence exams are for initial licensure, not CE replacement.
The Mentor's Analysis: Idaho treats pharmacists as advanced professionals capable of
self-directing their education. When renewing a license, the immediate priority is ensuring CE
aligns with actual clinical practice. By utilizing the standard-of-care attestation, you bypass the
trap of tracking arbitrary hour metrics. Professional/Academic Intuition: Competence is
measured by clinical relevance, not hours on a clock.
Q6: A patient requests Ivermectin over-the-counter (OTC). Under Idaho SB 1211, how MUST
the pharmacist proceed? A) Dispense the Ivermectin but mandate the patient sign a liability
waiver. B) Refuse the sale without a valid prescription. C) Sell the Ivermectin OTC and
optionally offer counseling on dosage and toxicity. D) Process the sale through the Idaho PDMP
, to monitor diversion.
● The Answer: C (Sell the Ivermectin OTC and optionally offer counseling on dosage and
toxicity)
● Distractor Analysis:
○ A is incorrect: SB 1211 does not require waivers; it deregulates the transaction.
○ B is incorrect: The statute explicitly allows the sale without a prescription.
○ D is incorrect: Ivermectin is not a controlled substance requiring PDMP tracking.
The Mentor's Analysis: Legislative mandates occasionally override traditional prescription
classifications. When handling SB 1211 requests, the immediate priority is compliance with the
OTC designation. By utilizing the optional counseling framework, you bypass the trap of
unlawfully obstructing a legally deregulated sale. Professional/Academic Intuition: Offer clinical
expertise, but do not use it as a barrier to an authorized OTC sale.
Q7: A pharmacy dispenses a Schedule III controlled substance on Tuesday at 2:00 PM. Under
Idaho Code 37-2730A, what is the ABSOLUTE DEADLINE to report this to the PDMP? A) By
2:00 PM on Wednesday. B) By the end of the business day on Tuesday. C) Within 72 hours of
dispensing. D) By Friday at 5:00 PM.
● The Answer: B (By the end of the business day on Tuesday)
● Distractor Analysis:
○ A is incorrect: The next-day reporting rule was legislatively amended to
end-of-business-day.
○ C is incorrect: 72 hours is a legacy metric for emergency oral C-II prescriptions.
○ D is incorrect: Weekly reporting severely violates rapid-tracking mandates.
The Mentor's Analysis: The speed of data dictates the effectiveness of prescription monitoring.
When dispensing a controlled substance, the immediate priority is real-time database integrity.
By utilizing end-of-day reporting, you bypass the trap of relying on outdated 24-hour grace
periods. Professional/Academic Intuition: If the drug leaves the pharmacy today, the data
hits the PDMP today.
Q8: A pharmacist-in-charge (PIC) is determining the technician-to-pharmacist ratio. Under the
current Idaho Pharmacy Act, which standard dictates this? A) A strict 1:6 ratio. B) A 1:8 ratio if
two technicians are nationally certified. C) Staffing must be adequate to safely provide services
under the applicable standard of care. D) A 1:3 ratio for dispensing, but unlimited for
administrative tasks.
● The Answer: C (Staffing must be adequate to safely provide services under the applicable
standard of care)
● Distractor Analysis:
○ A is incorrect: Fixed numerical ratios were abolished.
○ B is incorrect: The permanent statute relies entirely on professional judgment
regarding safety, not specific integer caps.
○ D is incorrect: Idaho does not artificially bifurcate dispensing vs. administrative
ratios in statute.
The Mentor's Analysis: Regulatory reform shifted operational safety from arbitrary math to
professional accountability. When staffing a facility, the immediate priority is evaluating workload
complexity versus staff competency. By utilizing standard-of-care principles, you bypass the trap
of relying on statutory integers. Professional/Academic Intuition: The limit is defined by safety,
not by a statutory number.
Q9: A drug outlet experiences a change in its majority ownership. Under Idaho Code 54-1731,
what is the required timeline for reporting this to the Board? A) At least 10 days prior. B)
Immediately upon signing. C) Within 30 days following the event. D) During the next biennial
